http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021514386-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-72 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 |
| filingDate | 2019-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2021514386-A |
| titleOfInvention | 5-Fluoro-4- (4-fluoro-2-methoxyphenyl) -N- {4-[(S-methylsulfonimideyl) methyl] pyridin-2- for the treatment of diffuse large B-cell lymphoma Use of yl} pyridin-2-amine |
| abstract | The present invention treats diffuse large B-cell lymphoma (DLBCL), especially embryo-centric B-cell diffuse large B-cell lymphoma, especially cells in the amplification or translocation of the MYC and / or BCL2 genes. 5-Fluoro-4- (4-fluoro-2-methoxyphenyl) -N- {4-[(S-) in diffuse large B-cell lymphoma with locus and / or overexpression of MYC and / or BCL2 Methylsulfoneimideyl) methyl] pyridine-2-yl} pyridine-2-amine (Compound A), and more particularly (+) 5-fluoro-4- (4-fluoro-2-methoxyphenyl) -N- {4- Regarding the use of [(S-methylsulfonimideyl) methyl] pyridine-2-yl} pyridine-2-amine (Compound A'). |
| priorityDate | 2018-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.